Express Scripts Holding Company (NASDAQ:ESRX) – Equities researchers at William Blair boosted their FY2017 earnings estimates for shares of Express Scripts Holding in a note issued to investors on Wednesday. William Blair analyst J. Kreger now anticipates that the company will post earnings per share of $7.00 for the year, up from their previous estimate of $6.98. William Blair also issued estimates for Express Scripts Holding’s Q4 2017 earnings at $2.06 EPS and FY2018 earnings at $7.66 EPS.

Express Scripts Holding (NASDAQ:ESRX) last posted its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.02. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The company had revenue of $25.35 billion during the quarter, compared to analyst estimates of $25.52 billion. During the same period in the prior year, the firm earned $1.57 earnings per share. The business’s quarterly revenue was up .5% on a year-over-year basis.

ILLEGAL ACTIVITY NOTICE: “FY2017 Earnings Estimate for Express Scripts Holding Company Issued By William Blair (NASDAQ:ESRX)” was first reported by American Banking News and is owned by of American Banking News. If you are reading this story on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this story can be read at https://www.americanbankingnews.com/2017/07/28/fy2017-earnings-estimate-for-express-scripts-holding-company-issued-by-william-blair-nasdaqesrx.html.

Other research analysts have also issued reports about the company. Needham & Company LLC initiated coverage on Express Scripts Holding in a report on Friday, July 21st. They issued a “hold” rating on the stock. BidaskClub lowered Express Scripts Holding from a “hold” rating to a “sell” rating in a report on Wednesday, July 12th. Cowen and Company reaffirmed an “outperform” rating and issued a $83.00 price objective on shares of Express Scripts Holding in a report on Friday, June 9th. ValuEngine lowered Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Finally, Evercore ISI decreased their price objective on Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating on the stock in a report on Wednesday, April 26th. Four research analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $70.81.

Shares of Express Scripts Holding (NASDAQ:ESRX) opened at 62.33 on Friday. The firm’s 50-day moving average is $63.04 and its 200-day moving average is $65.23. The stock has a market capitalization of $36.99 billion, a price-to-earnings ratio of 11.30 and a beta of 0.90. Express Scripts Holding has a 1-year low of $57.80 and a 1-year high of $77.61.

In other news, VP Phyllis S. Anderson sold 1,100 shares of the company’s stock in a transaction on Friday, May 19th. The stock was sold at an average price of $60.08, for a total transaction of $66,088.00. Following the completion of the sale, the vice president now directly owns 11,108 shares in the company, valued at approximately $667,368.64. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.68% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in shares of Express Scripts Holding by 1.6% in the first quarter. Vanguard Group Inc. now owns 40,251,311 shares of the company’s stock valued at $2,652,964,000 after buying an additional 649,400 shares in the last quarter. State Street Corp increased its stake in shares of Express Scripts Holding by 1.1% in the first quarter. State Street Corp now owns 27,060,709 shares of the company’s stock valued at $1,783,569,000 after buying an additional 298,341 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC increased its stake in shares of Express Scripts Holding by 4.2% in the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 17,612,834 shares of the company’s stock valued at $1,160,862,000 after buying an additional 704,218 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of Express Scripts Holding by 0.3% in the first quarter. Bank of New York Mellon Corp now owns 10,960,709 shares of the company’s stock valued at $722,420,000 after buying an additional 32,854 shares in the last quarter. Finally, Macquarie Group Ltd. increased its stake in shares of Express Scripts Holding by 2.8% in the first quarter. Macquarie Group Ltd. now owns 10,958,513 shares of the company’s stock valued at $722,275,000 after buying an additional 296,452 shares in the last quarter. Hedge funds and other institutional investors own 88.38% of the company’s stock.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Earnings History and Estimates for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.